Compare Incyte Corporation (INCY) vs Realty Income Corp (O) Price & Performance

Incyte CorporationTrade

Realty Income CorpTrade

Price performance (Past 24H)

Key statistics

Incyte Corporation vs Realty Income Corp — how do they compare? Incyte Corporation trades at $115.7 (market cap $23.11B), while Realty Income Corp trades at $64.96 (market cap $60.78B). The key difference: Realty Income Corp is far larger — about 2.6× Incyte Corporation's market cap, and Realty Income Corp pays a 4.99% dividend while Incyte Corporation pays none. Which is the better fit depends on your goals.

	INCY	O
Market Cap	$23.11B	$60.78B
Sector	Health	Real Estate
52-Week High	$118.52	$67.56
52-Week Low	$67.38	$55.93
Enterprise Value	$19.13B	$90.58B
Dividend Yield	—	4.99%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INCY

Over 180 companies develop 200+ PD-1/PD-L1 inhibitors, reshaping cancer treatment landscape.Delveinsight · 4 hours agoBullish View details →

Realty Income rated Hold as Q1 growth driven by one-offs, dividend growth slows, and refinancing risks rise.Seeking Alpha · 8 hours agoNeutral Realty Income raises 2026 growth guidance, offers strong 5.14% yield and low-risk retail portfolio.Seeking Alpha · 15 hours agoBullish Realty Income REIT shows strong occupancy and dividend growth but valuation limits upside, rated Hold.Seeking Alpha · 1 day agoNeutral View details →

About Incyte Corporation

Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.

About Realty Income Corp

Realty Income owns roughly 11,400 properties, most of which are freestanding, single-tenant, triple-net-leased retail properties. Its properties are located in 49 states and Puerto Rico and are leased to 250 tenants from 47 industries. Recent acquisitions have added industrial, office, manufacturing, and distribution properties, which make up roughly 17% of revenue.